Elsevier Announces the Launch of Open Access Journal: Oral and Maxillofacial Surgery Cases

NEW YORK, July 28, 2014 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Oral and Maxillofacial Surgery Cases, an open access, surgical journal.

The journal will publish case reports and case series that are prospective or retrospective and examine the outcomes of management in more than one patient. Cases may include new or modified methodology and treatment, uncommon findings, and mechanisms in oral and maxillofacial surgery cases.

Dr. Janice Lee, Deputy Clinical Director of the National Institute of Dental and Craniofacial Research at the NIH, and Editor-in-Chief of Oral and Maxillofacial Surgery Cases, explained, "I am pleased to work with Elsevier and the editorial board to provide this new resource to authors. We hope that this open access forum will offer stimulating, relevant, concise, and hypothesis-generating case reports and series."

Elizabeth Perill, Executive Publisher for Oral and Maxillofacial Surgery Cases at Elsevier said, "We see wonderful opportunities to better serve the oral and maxillofacial surgery community by publishing this open access case reports journal. Oral and Maxillofacial Surgery Cases will be a strong addition to Elsevier's open access journals."

For more information go to:

http://www.oralandmaxillofacialsurgerycases.com

http://www.journals.elsevier.com/oral-and-maxillofacial-surgery-cases

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Natalie Hill-krasniqi
Elsevier
+44-20-7424-4404
n.hill-krasniqi@elsevier.com